GlycoMimetics
GLYC
$1.64
Share price
-4.09%
Change (1 day)
19.71%
Change (1 year)
Categories
EPS for GlycoMimetics (GLYC)
EPS in 2023 (TTM): -$0.65
According to GlycoMimetics 's latest financial reports the company's current EPS (TTM) is -$0.65. In 2022 the company made an earnings per share (EPS) of -$0.88 an increase over its 2021 EPS that were of -$1.23.
EPS history for GlycoMimetics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.65 | -26.14% |
| 2022 | -$0.88 | -28.46% |
| 2021 | -$1.23 | 10.81% |
| 2020 | -$1.11 | -17.78% |
| 2019 | -$1.35 | 14.41% |
| 2018 | -$1.18 | 2.61% |
| 2017 | -$1.15 | -23.84% |
| 2016 | -$1.51 | 125.37% |
| 2015 | -$0.67 | 8.06% |
| 2014 | -$0.62 | -92.09% |
| 2013 | -$7.84 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -2,266.97% | 🇺🇸 USA |
 Pfizer PFE | $1.86 | -386.15% | 🇺🇸 USA |
 Sanofi SNY | $3.18 | -589.27% | 🇫🇷 France |
 Palatin Technologies PTN | -$2.96 | 355.38% | 🇺🇸 USA |
 bluebird bio
BLUE | -$1.02 | 56.92% | 🇺🇸 USA |